Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM) Stock Price, Quote & AI Analysis

Live QNTM stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Quantum Biopharma Ltd. Class B Subordinate Voting Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

Q
QNTM
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$18,869,017.07
52W Range
$2.07 - $38.25
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Quantum Biopharma Ltd. Class B Subordinate Voting Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Quantum Biopharma Ltd. Class B Subordinate Voting Shares Overview

Company information

Company Overview

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Company Details
Market Cap
$16.60M
Shares Outstanding
4,161,123
Weighted Shares Outstanding
3,842,977
CEO
Zeeshan Saeed
Employees
7
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Quantum Biopharma Ltd. Class B Subordinate Voting Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...